MRI of Cardiotoxicity.

Area of Science:

• Cardiology
• Oncology
• Medical Imaging

Background:

• Echocardiography can be limited by poor acoustic windows, leading to inconclusive left ventricular ejection fraction (LVEF) measurements.
• Accurate LVEF assessment is crucial for diagnosing and managing cardiovascular conditions, especially in complex patient populations.

Purpose of the Study:

• To highlight the utility of Cardiovascular Magnetic Resonance (CMR) imaging in situations where echocardiography is suboptimal.
• To emphasize CMR's role in cardio-oncology for tissue characterization and differential diagnosis.
• To underscore the increasing application of CMR in screening and surveillance of cardio-oncology patients.

Main Methods:

• Cardiovascular magnetic resonance (CMR) imaging utilizes magnetic fields and radio waves to create detailed images of the heart.
• Tissue characterization techniques within CMR allow for noninvasive assessment of myocardial tissue properties.
• Comparison with echocardiography and other modalities for LVEF assessment.

Main Results:

• CMR provides accurate LVEF measurements when echocardiography is limited by poor acoustic windows.
• CMR enables noninvasive tissue characterization to identify treatment-related cardiac pathology.
• CMR assists in differentiating cardiac conditions that may mimic or complicate presentations in cardio-oncology.

Conclusions:

• Cardiovascular magnetic resonance (CMR) imaging is a valuable tool for precise systolic function assessment, particularly when echocardiography is inadequate.
• CMR's tissue characterization capabilities are advantageous in cardio-oncology for monitoring treatment effects and clarifying diagnoses.
• The use of CMR is expanding for the screening and surveillance of patients undergoing cancer therapy due to its comprehensive cardiac evaluation.